Tabassum, Sartaj, Singh, Ruchi, Zaki, Mehvash, Ahmad, Musheer, Afzal, Mohd. (2015) Synthesis and crystal structure determination of a mononuclear cobalt(ii) complex derived from 4-(pyridin-4-ylmethoxy)-benzoic acid: evaluation of the DNA/protein interaction and photo-induced pBR322 DNA cleavage. RSC Advances, 5 (45). 35843-35851 doi:10.1039/c5ra01611h

See Also

These are possibly similar items as determined by title/reference text matching only.

	Tabassum, Sartaj, Ahmad, Musheer, Afzal, Mohd, Zaki, Mehvash, Faizi, Md. Serajul Haque, Ali, Akram (2016) Synthesis and crystal structure determination of cobalt(II) mixed-ligand complex containing 1,10-phenanthroline and 5-(2-carboxybenzyloxy)isophthalic acid: Their biological evaluation viz. DNA/protein binding profile, pBR322 DNA cleavage activity. Inorganica Chimica Acta, 451. 216-226 doi:10.1016/j.ica.2016.07.033
	Tabassum, Sartaj, Afzal, Mohd., Al–Lohedan, Hamad, Zaki, Mehvash, Khan, Rais Ahmad, Ahmad, Musheer (2017) Synthesis and structure elucidation of new open cubane tetranuclear [Cu II 4 ] Cluster: Evaluation of the DNA/HSA interaction and pBR322 DNA cleavage pathway and cytotoxicity. Inorganica Chimica Acta, 463. 142-155 doi:10.1016/j.ica.2017.04.031
	Tabassum, Sartaj, Zaki, Mehvash, Afzal, Mohd., Arjmand, Farukh (2013) New modulated design and synthesis of quercetin–CuII/ZnII–Sn2IV scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity. Dalton Transactions, 42 (27). 10029pp. doi:10.1039/c3dt50646k
	Usman, Mohammad, Zaki, Mehvash, Khan, Rais Ahmad, Alsalme, Ali, Ahmad, Musheer, Tabassum, Sartaj (2017) Coumarin centered copper(ii) complex with appended-imidazole as cancer chemotherapeutic agents against lung cancer: molecular insight via DFT-based vibrational analysis. RSC Advances, 7 (57). 36056-36071 doi:10.1039/c7ra05874h
	Parveen, Sabiha, Tabassum, Sartaj, Arjmand, Farukh (2017) Synthesis of chiral R/S-pseudopeptide-based Cu(ii) & Zn(ii) complexes for use in targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA and pBR322 DNA hydrolytic cleavage mechanism. RSC Advances, 7 (11). 6587-6597 doi:10.1039/c6ra24770a
	Yousuf, Imtiyaz, Arjmand, Farukh, Tabassum, Sartaj, Ahmad, Musheer (2019) Design and synthesis of a DNA intercalative half-sandwich organoruthenium(ii)–chromone complex: cytotoxicity evaluation and topoisomerase Iα inhibition assay. New Journal of Chemistry, 43. 5475-5487 doi:10.1039/c9nj00042a
	Yadav, Shipra, Yousuf, Imtiyaz, Usman, Mohammad, Ahmad, Musheer, Arjmand, Farukh, Tabassum, Sartaj (2015) Synthesis and spectroscopic characterization of diorganotin(iv) complexes of N′-(4-hydroxypent-3-en-2-ylidene)isonicotinohydrazide: chemotherapeutic potential validation by in vitro interaction studies with DNA/HSA, DFT, molecular docking and cytotoxic activity. RSC Advances, 5 (63). 50673-50690 doi:10.1039/c5ra06953j
	Tabassum, Sartaj, Al–Asbahy, Waddhaah M., Afzal, Mohd., shamsi, Manal, Arjmand, Farukh (2012) DNA binding and cleavage studies of new sulfasalazine-derived dipeptide Zn(II) complex: Validation for specific recognition with 5′–TMP. Journal of Luminescence, 132 (11) 3058-3065 doi:10.1016/j.jlumin.2012.05.040
	Yousuf, Imtiyaz, Zeeshan, Mohd, Arjmand, Farukh, Rizvi, Masood Ahmad, Tabassum, Sartaj (2019) Synthesis, structural investigations and DNA cleavage properties of a new water soluble Cu(II)–iminodiacetate complex. Inorganic Chemistry Communications, 106. 48-53 doi:10.1016/j.inoche.2019.05.027
	Ali, Mohd Sajid, Tabassum, Sartaj, Al-Lohedan, Hamad A., Farah, Mohammad Abul, Al-Anazi, Khalid Mashay, Usman, Mohammad (2019) Fluorescent delivery vehicle containing cobalt oxide–umbelliferone nanoconjugate: DNA/protein interaction studies and anticancer activity on MF7 cancer cell line. RSC Advances, 9 (45). 26503-26518 doi:10.1039/c9ra02412c
	Tabassum, Sartaj, Asim, Ahmad, Khan, Rais Ahmad, Arjmand, Farukh, Rajakumar, Dhivya, Balaji, Perumalsamy, Akbarsha, Mohammad Abdulkader (2015) A multifunctional molecular entity CuII–SnIV heterobimetallic complex as a potential cancer chemotherapeutic agent: DNA binding/cleavage, SOD mimetic, topoisomerase Iα inhibitory and in vitro cytotoxic activities. RSC Advances, 5 (59). 47439-47450 doi:10.1039/c5ra07333b